| Active substance | |
|---|---|
| Water Retention | |
| Hepatotoxicity | |
| Lab Test | Monitoring is not typically required for liver enzymes unless under specific medical advice |
| Strength | |
| Also known as | |
| Blood pressure | |
| Trade name | |
| Storage conditions | |
| Chemical name | |
| Formula | |
| Substance class | |
| Main action | |
| Half-life | |
| Dosage (medical) | |
| Dosage (sports) | |
| Effects | Reduces inflammation by inhibiting PDE4, an enzyme involved in the process of inflammatory response |
| Side effects | Diarrhea, nausea, headache, upper respiratory tract infection, weight loss |
| Use in sports | Not typically used in sports, lacks performance-enhancing properties |
| Manufacturer | |
| Packing |
Aprezo 30 mg Glenmark Pharmaceuticals Ltd.
£36.00